GlassScriptPhysician profile
Ashish Mukherjee
NPI 1710997259
$2,133.04
in general payments reported to CMS, 2019-2025
25 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2020: $111 · 2021: $95.98 · 2022: $147 · 2023: $269 · 2024: $457 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.22 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $540.00 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $236.52 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $234.86 | 2019 | |
| Novartis Pharmaceuticals Corporation | $168.87 | 2019-2024 | |
| Inari Medical, INC. | $141.69 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $116.09 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $88.63 | 2020-2023 | Xarelto |
| Cardiovascular Systems INC. | $77.27 | 2019 | |
| Medtronic, INC. | $64.80 | 2021 | |
| Cvrx, INC. | $57.76 | 2022-2024 | Barostim Neo System |
| Amgen INC. | $51.00 | 2019-2023 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $46.46 | 2025 | |
| Pfizer INC. | $41.51 | 2019-2024 | |
| Philips North America LLC | $34.10 | 2025 | Holter |
| Lilly USA, LLC | $33.46 | 2024 | Mounjaro, Zepbound |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $33.25 | 2019-2021 | |
| Lantheus Medical Imaging, INC. | $29.83 | 2023 | Definity |
| Scpharmaceuticals INC. | $25.00 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.19 | 2023 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $18.03 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $17.03 | 2019 | |
| Allergan, INC. | $15.22 | 2019 | |
| Edwards Lifesciences Corporation | $13.70 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astellas Pharma US INC | $12.51 | 2019 | |
| Cook Medical LLC | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Mukherjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.